s'authentifier
version française rss feed
Fiche concise
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection.
Rivière Y., Montange T., Janvier G., Marnata C., Durrieu L., Chaix M.-L., Isaguliants M., Launay O., Bresson J.-L., Pol S.
Virology Journal 9, 1 (2012) 76 - http://www.hal.inserm.fr/inserm-00705314
(22455516)
Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection.
Yves Rivière () 1, Thomas Montange1, Geneviève Janvier1, Caroline Marnata1, Ludovic Durrieu1, Marie-Laure Chaix2, Maria Isaguliants3, Odile Launay4, Jean-Louis Bresson5, Stanislas Pol6, 7
1 :  Immunopathologie Virale
Institut Pasteur de Paris – CNRS : URA3015
25-28 rue du Docteur Roux, F-75724 Paris Cedex 15
France
2 :  Pharmacologie des antirétroviraux
Université Paris V - Paris Descartes : EA3620
France
3 :  Institute for Microbiology, Tumor and Cell Biology
Karolinska Institutet
17177 Stockholm
Suède
4 :  CIC - Biotherapie - AP-HP (cochin - Pasteur)
INSERM : CBT505
Hopital Cochin PARIS V 27, Rue du Faubourg Saint-Jacques 75679 PARIS CEDEX 14
France
5 :  CIC - Biotherapie - Necker - Hegp - Cochin
INSERM : CBT502
Fac de Medecine Necker Enfants Malades PARIS V 156, Rue de Vaugirard 75015 PARIS
France
6 :  Institut Cochin
INSERM : U1016 – CNRS : UMR8104 – Université Paris V - Paris Descartes
22 rue Méchain, 75014 Paris
France
7 :  Service d'hépatologie médicale [Cochin]
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôpital Cochin – Université Paris V - Paris Descartes
27, rue du Faubourg Saint-Jacques 75014 Paris
France
ABSTRACT: The detection of hepatitis C virus (HCV)-specific T cell responses in HCV-uninfected, presumably unexposed, subjects could be due to an underestimation of the frequency of spontaneously resolving infections, as most acute HCV infections are clinically silent. To address this hypothesis, HCV-specific cellular immune responses were characterized, in individuals negative for an HCV PCR assay and humoral response, with (n=32) or without (n=33) risk of exposure to HCV. Uninfected volunteers (n=20) with a chronically HCV-infected partner were included as positive controls for potential exposure to HCV and HCV infection, respectively. HCV-specific T cell responses in freshly isolated peripheral blood mononuclear cells were studied ex vivo by ELISPOT and CFSE-based proliferation assays using panels of HCV Core and NS3-derived peptides. A pool of unrelated peptides was used as a negative control, and a peptide mix of human cytomegalovirus, Epstein-Bar virus and Influenza virus as a positive control. Overall, 20% of presumably HCV-uninfected subject tested had detectable T-cell responses to the virus, a rate much higher than previous estimates of HCV prevalence in developed countries. This result would be consistent with unapparent primary HCV infections that either cleared spontaneously or remained undetected by conventional serological assays.
Sciences du Vivant/Médecine humaine et pathologie/Maladies infectieuses
Anglais
1743-422X

Articles dans des revues avec comité de lecture
10.1186/1743-422X-9-76
Virology Journal
Publisher BioMed Central
ISSN 1743-422X 
internationale
28/03/2012
28/03/2012
9
1
76

HCV – Prevalence – Proliferation – Elispot – Inapparent infection
This research has been supported in part by grant from l'Agence Nationale de Recherches sur le SIDA et les hépatites virales, from INSERM, Aventis and Institut Pasteur
Liste des fichiers attachés à ce document : 
PDF
1743-422X-9-76.pdf(277.7 KB)
ANNEX
1743-422X-9-76.xml(155.8 KB)